Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioCryst Pharmaceuticals, Inc. (NQ: BCRX)
1.590 USD  -0.070 (-4.22%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about BioCryst Pharmaceuticals, Inc.
 
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
BioCryst Pharma (BCRX) Presents Phase 2 Data for Forodesine as CLL Treatment
December 06, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6144205 for the full story. Read More
from StreetInsider.com News Articles
After Yesterday's Decline of 1.69%, BioCryst Pharmaceuticals Offers Investors Better Value (BCRX)
November 18, 2010
from Comtex SmarTrend® News Briefs
U.S. awards $1 billion to small biotechs
November 03, 2010
WASHINGTON, Nov 3 (Reuters) - The U.S. government announced $1 billion worth of small grants to small biotechnology companies to boost research and support jobs. Read More
category companyNews
from Reuters: Company News
BioCryst Pharma (BCRX) Posts Q3 Loss of $0.24, Wider than Views
October 28, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6058216 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 10/28: Microsoft (MSFT), First Solar (FSLR), Potash Corp. (POT), Motorola (MOT) Report
October 27, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6056713 for the full story. Read More
from StreetInsider.com News Articles
BioCryst (BCRX) Lab Acquired by Southern Research Institute
October 14, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6031573 for the full story. Read More
from StreetInsider.com News Articles
Rodman & Renshaw Upgrades BioCryst Pharmaceuticals (BCRX) to Market Outperform
September 29, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6003298 for the full story. Read More
from StreetInsider.com News Articles
BioCryst Pharmaceuticals (BCRX) Downgraded at BofA/Merrill
September 23, 2010
from Comtex SmarTrend® News Briefs
BioCryst (BCRX) Shares Moving Lower as BofA Merrill Downgrades to Underperform
September 23, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5993582 for the full story. Read More
from StreetInsider.com News Articles
BioCryst Announces Positive Results of Potential Gout Treatment
September 16, 2010
Shares of BioCryst Pharmaceuticals surged Thursday after the drugmaker reported positive clinical results of a potential treatment for gout. Read More
from FOXBusiness.com
BioCryst Announces Positive Results of Potential Gout Treatment
September 16, 2010
Shares of BioCryst Pharmaceuticals surged Thursday after the drugmaker reported positive clinical results of a potential treatment for gout. Read More
from FOXBusiness.com
Thursday’s biggest gaining and declining stocks
September 16, 2010
MarketWatch’s daily rundown of major gainers and decliners in the U.S. stock market. Read More
category F , Computer Software , SBGSY , and 26 more.
from MarketWatch
BioCryst Pharma (BCRX) Announces Postive Data from BCX4208 Phase 2
September 16, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5975139 for the full story. Read More
from StreetInsider.com News Articles
BioCryst Pharma (BCRX) Presents Top-Line Data from Forodesine Phase 2 in CTCL and CLL
September 15, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5971935 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Savient's gout drug gets FDA approval
September 14, 2010
Sept 14 (Reuters) - The U.S. Food and Drug Administration approved the use of Savient Pharmaceuticals Inc's gout drug in adults who do not respond to other treatments or cannot take alternatives for... Read More
category companyNews
from Reuters: Company News
BioCryst Pharmaceuticals Hits a New 52-Week Low (BCRX)
August 25, 2010
from Comtex SmarTrend® News Briefs
Earnings Flashback: Since Reporting Quarterly Results 15 Days Ago BioCryst Pharmaceuticals Is Down 17.64% (BCRX)
August 23, 2010
from Comtex SmarTrend® News Briefs
SmarTrend Detects Broken Support Level In Shares of BioCryst Pharmaceuticals (BCRX)
August 23, 2010
from Comtex SmarTrend® News Briefs
Look for Shares of BioCryst Pharmaceuticals to Rebound after Yesterday's 4.44% Sell Off (BCRX)
August 20, 2010
from Comtex SmarTrend® News Briefs
Traders Abandon Ship on Shares of BioCryst Pharmaceuticals, Shares Down 5.4% (BCRX)
August 19, 2010
from Comtex SmarTrend® News Briefs
Previous 52-Week Low Surpassed in Shares of BioCryst Pharmaceuticals (BCRX)
August 16, 2010
from Comtex SmarTrend® News Briefs
Watch for BioCryst Pharmaceuticals to Rebound after Falling 8.51% Yesterday (BCRX)
August 12, 2010
from Comtex SmarTrend® News Briefs
Breathe Easier: WHO Declares H1N1 "Swine Flu" Pandemic Over
August 10, 2010
Though the threat of H1N1 infection remains, the World Health Organization has declared an end to the Swine Flu pandemic, citing "pure good luck" to explain why the disease wasn't as lethal as feared.... Read More
category NVAX , BCRX , swine flu , and 8 more.
from DailyFinance.com
Watch for BioCryst Pharmaceuticals to Rebound after Falling 5.50% Yesterday (BCRX)
August 06, 2010
from Comtex SmarTrend® News Briefs
BioCryst Pharma (BCRX) Misses Q2 Views; Updates on BCX4208 Phase 2a
August 05, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5867139 for the full story. Read More
from StreetInsider.com News Articles
Barbell investing is the new normal
August 02, 2010
Your only defense is to view your portfolio as a barbell. On one end should be extremely safe investments that will give you a fighting chance against inflation, deflation or whatever comes -- with... Read More
category Earnings , Biotechnology , TNK , and 21 more.
from MarketWatch
Earnings Alert: BioCryst Pharmaceuticals is Expected to Beat the Street Consensus When It Reports Earnings (BCRX)
July 29, 2010
from Comtex SmarTrend® News Briefs
Earnings Watch: BioCryst Pharmaceuticals is Scheduled to Report its Quarterly Results in 4 days (BCRX)
July 26, 2010
from Comtex SmarTrend® News Briefs
BioCryst Pharmaceuticals In Review: Shares Trading 20% Below its March 23rd 'Healthcare Bill Signing' Low of $6.69 (BCRX)
July 22, 2010
from Comtex SmarTrend® News Briefs
Earnings Update: BioCryst Pharmaceuticals Releases its Quarterly Earnings on July 30, 2010 (BCRX)
July 18, 2010
from Comtex SmarTrend® News Briefs
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here